Christian Béchon
Directeur/Bestuurslid bij CHECKPOINT THERAPEUTICS, INC.
Vermogen: 162 631 $ op 30-04-2024
Profiel
Christian Béchon currently works at CHB Consultants Ltd., as Chairman & Chief Executive Officer from 2018, France Biotech Association, as Director from 2014, and Checkpoint Therapeutics, Inc., as Independent Director from 2018.
Mr. Béchon also formerly worked at LFB Biotechnologies SASU, as Chairman & Chief Executive Officer from 2012 to 2017, Laboratoire Français du Fractionnement et des Biotechnologies, as Chairman, President & Chief Executive Officer from 2010 to 2012, Quantum Genomics SA, as Director, rEVO Biologics, Inc., as Independent Director from 2006 to 2015, and Centre National d'Etudes Spatiales EPIC, as General Secretary in 1995.
Mr. Béchon received his undergraduate degree from Sciences Po and undergraduate degree from École Centrale Paris.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
14-05-2024 | 114 529 ( 0.33% ) | 162 631 $ | 30-04-2024 |
Actieve functies van Christian Béchon
Bedrijven | Functie | Begin |
---|---|---|
CHECKPOINT THERAPEUTICS, INC. | Directeur/Bestuurslid | 16-10-2018 |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Directeur/Bestuurslid | 12-06-2014 |
CHB Consultants Ltd. | Algemeen Directeur | 01-01-2018 |
Eerdere bekende functies van Christian Béchon
Bedrijven | Functie | Einde |
---|---|---|
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Algemeen Directeur | 04-12-2017 |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Algemeen Directeur | 01-01-2017 |
Centre National d'Etudes Spatiales EPIC | Bedrijfssecretaris | 01-06-1995 |
REVO BIOLOGICS INC | Directeur/Bestuurslid | - |
QUANTUM GENOMICS | Directeur/Bestuurslid | - |
Opleiding van Christian Béchon
Sciences Po | Undergraduate Degree |
École Centrale Paris | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
QUANTUM GENOMICS | Health Technology |
CHECKPOINT THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
Centre National d'Etudes Spatiales EPIC | Government |
CHB Consultants Ltd. |